Clinical Innovation in Aesthetic Cosmetology: The Role of Research and Professional Expertise in levgeniia lasinskaʼs Work
Aesthetic cosmetology is increasingly moving beyond “beauty procedures.” Today, it is much closer to the logic of clinical disciplines — grounded in evidence, risk control, long-term protocols, and predictable outcomes. This is especially evident in acne care: a chronic condition with a relapsing course that affects not only the skin but also self-esteem — and, consequently, patients’ quality of life.
This trend is clearly reflected in the approach of levgeniia lasinska, a cosmetologist-pharmacist with nearly 20 years of experience in cosmetology and a licensed facial specialist in the state of Florida (USA). Her professional profile combines hands-on practice, pharmaceutical thinking, and systematic work in educational initiatives, as well as sc даientific publications focu поsed on the effectiveness of acne-related skincare.
Delivery system or active concentration — what matters more?
One of the key ideas in modern dermocosmetology is moving away from the “the stronger, the better” mindset. Active ingredients may be effective in theory, but in practice this is far from always the case. The results of such ingredients are often determined by formula stability, release rate, and how the skin interacts with them — not in theory, but under real-world conditions of use.
It is precisely at this intersection between laboratory potential and clinical reality that lasinska’s research, “Innovative sustained-release retinol systems in the therapy of chronic acne,” is situated.
The study examines retinol — a form of vitamin A and a powerful cosmetic ingredient that has significant limitations for long-term use in acne-prone patients due to instability and an increased risk of irritation.
Why retinol often fails in real-life acne routines
In her research, lasinska notes that the main factor limiting retinol use is its inherent instability. Under the influence of light, oxygen, heat, and other external factors, the active molecule rapidly degrades. In practice, this means two things. First, the actual dose of the vitamin that reaches the skin decreases — along with the ability to predict the outcome. Second, irritation risk increases, which may be related not so much to retinol itself as to its degradation products. In clinical practice, this is often perceived as “retinoid intolerance” and leads to discontinuation of therapy. “At this stage, patients often conclude that retinol ‘doesn’t suit them,’ although the issue may lie in formula stability and the way it is introduced into the routine.”
levgeniia lasinska emphasizes cause-and-effect mechanisms: “If irritation is driven by formula instability, then the strategy should be built not on endlessly lowering the concentration, but on improving the delivery system.”
What controlled release offers
Chronic acne requires long-term solutions — and patience from the patient. However, classic retinol products often trigger a “harsh start” that can be discouraging. “Dryness, erythema, flaking, uncomfortable sensations such as burning — these are the reasons patients stop using retinol on average within 7–14 days,” says lasinska. And this, in her view, is one of the typical reasons why promising regimens fail in real life.
Modified delivery systems change the kinetics of retinol–skin interaction: active substances are released evenly and in a controlled manner, without peak concentrations on the surface. This creates a gentler — yet longer-lasting — effect in deeper layers, where retinol’s key mechanisms are realized (normalization of keratinization, reduced comedogenesis, and anti-inflammatory action).
This is how retinol shifts from being purely a “cosmetic active” to becoming an element of maintenance therapy.
Retinol carriers: what encapsulation changes — and why systems are not the same
lasinska’s work analyzes innovative carriers that provide sustained and controlled retinol delivery: polymer and solid lipid nanoparticles, lipid nanocapsules, glycospheres, and silicone microparticles. However, there are differences among them: while these systems may share the same goal (stability and release control), they vary in penetration depth, potential accumulation, impact on the skin barrier, and interactions with other actives. Some platforms demonstrate more targeted penetration into the follicle — an aspect that is particularly critical in acne care.
That is why the question “does retinol work?” is increasingly being replaced by another one: in which form does it work predictably and without excessive skin reactivity?
Clinical relevance: tolerability, remission, and skin quality
The available data supporting lasinska’s analysis suggest that encapsulated retinol, in clinical observations, is associated with better tolerability and a lower incidence of adverse reactions compared to conventional forms. This directly affects treatment adherence — and therefore the stability of the results achieved.
Also highlighted is the potential for long-term benefits. A reduction in inflammatory lesions and comedones leads to improved skin condition during remission: texture becomes more even, post-inflammatory hyperpigmentation decreases, and the skin barrier receives much-needed support.
This does not mean irritation disappears entirely, but it becomes more manageable.
From scientific conclusions to educational practice: working with teenagers as part of a clinical logic
For levgeniia lasinska, acne is not only a dermatological condition but also a socio-psychological factor—especially in adolescent patients. She is the author of a publication on indicators of implementation and “fidelity” to skincare programs and their relationship to clinical benefits and adolescents’ confidence. She also created and implemented an educational initiative for school students and university students aimed at building a skincare culture and preventing acne as a component of psychological confidence.
Her educational work has been recognized by city authorities and the regional administration. A logical continuation of this direction became Skin Confidence Method — an author-developed methodology for acne prevention and building self-confidence in teenagers.
The professional environment as an indicator of standards
When discussing innovation in cosmetology, it is important to consider not only individual practice but also engagement with professional institutions. lasinska is a speaker and expert at INSTYTUTUM Academy, a participant in профильні conferences, forums, and congresses, and an active member of professional initiatives such as the Committee for Beauty Salon Standards, the Association of Aesthetic Medicine Professionals, and the Eurasian Beauty Guild.
Her work has been covered in the media, including ELLE and gazeta.ua. She is a winner and a judge of international cosmetology championships. Her distinctions include IBA TOP SKIN SPECIALIST and IBA INNOVATOR IN SKINCARE Treatments (2021), the “Quality Mark” status (2022), IBA EXCELLENCE in Facial Therapy (2024), and “Famous Women of Ukraine” (2025).
Moving in the right direction: personalized protocols
One of the most promising directions outlined in lasinska’s work is the development of interdisciplinary approaches at the intersection of dermatology, cosmetology, nanotechnology, and bioengineering. “Smart” carriers that respond to changes in pH, temperature, enzymatic activity, or inflammation may form a new class of adaptive delivery systems — and with it, personalized strategies for acne therapy.
Ultimately, research into sustained-release retinol systems leads to a practical conclusion: in modern aesthetic cosmetology, innovation increasingly means not “stronger ingredients,” but better pharmacokinetics, stability, and tolerability. These are the factors that determine long-term outcomes.
levgeniia lasinska’s case clearly illustrates how professional expertise — from licensed clinical practice to scientific analysis and educational programs — can translate theoretical principles into consistent, real-world approaches to skincare for chronic acne.
